A 2026 Top 5 #ASNKidney360 reviewer, Dr. Luis Rafael Álvarez Velázquez, shares: “Peer review allows us not only to safeguard scientific rigor, but also to help colleagues communicate their findings more clearly so research can ultimately improve patient care.” #PRW2026
October 23, 2026 at 3:30 PM
A 2026 Top 5 #ASNKidney360 reviewer, Dr. Luis Rafael Álvarez Velázquez, shares: “Peer review allows us not only to safeguard scientific rigor, but also to help colleagues communicate their findings more clearly so research can ultimately improve patient care.” #PRW2026
Discussing peer review, Devika Nair, MD, noted: “I view peer review as an opportunity to help my colleagues strengthen the validity, clarity, and impact of their work, after first highlighting their hard-won scientific contributions.” Top 5 #ASNCJASN reviewer 2026. #PRW2026
October 21, 2026 at 4:30 PM
As a 2026 top 5 #ASNJASN reviewer, Dr. Sandeep K. Mallipattu notes “Peer review is where scientific progress meets shared purpose. It’s an opportunity for the research community to challenge, refine, and strengthen one another’s work in service of knowledge we can trust.” #PRW2026
October 19, 2026 at 4:30 PM
A 2026 Top 5 #ASNKidney360 reviewer, Dr. Keiichi Sumida, reflects: “Peer review is a pillar of scholarly work, strengthening the integrity and quality of published research while providing an opportunity to offer fair, rigorous, and constructive feedback.” #PRW2026
October 16, 2026 at 5:29 PM
A 2026 Top 5 #ASNKidney360 reviewer, Dr. Keiichi Sumida, reflects: “Peer review is a pillar of scholarly work, strengthening the integrity and quality of published research while providing an opportunity to offer fair, rigorous, and constructive feedback.” #PRW2026
Thank you to Dr. Jonathan Zuckerman, a 2026 Top 5 #ASNCJASN reviewer, who shared: “Peer review is an important service to the nephrology and renal pathology community. Thoughtful review sharpens scientific interpretation and clinical relevance.” #PRW2026
@jzrenalpath.bsky.social
@jzrenalpath.bsky.social
October 14, 2026 at 3:03 PM
Thank you to Dr. Jonathan Zuckerman, a 2026 Top 5 #ASNCJASN reviewer, who shared: “Peer review is an important service to the nephrology and renal pathology community. Thoughtful review sharpens scientific interpretation and clinical relevance.” #PRW2026
@jzrenalpath.bsky.social
@jzrenalpath.bsky.social
We asked Volker Vallon, MD, FASN, one of the Top 5 #ASNJASN reviewers of 2026, for his thoughts on the benefits of peer review: “Peer review provides me with an opportunity to learn from my peers and provide them with critical and constructive feedback.” #PRW2026
@ucsdmedschool.bsky.social
@ucsdmedschool.bsky.social
October 12, 2026 at 2:58 PM
We asked Volker Vallon, MD, FASN, one of the Top 5 #ASNJASN reviewers of 2026, for his thoughts on the benefits of peer review: “Peer review provides me with an opportunity to learn from my peers and provide them with critical and constructive feedback.” #PRW2026
@ucsdmedschool.bsky.social
@ucsdmedschool.bsky.social
For Satoshi Minami, MD, PhD, a 2026 Top 5 #ASNKidney360 reviewer, peer review is “a valuable opportunity to support colleagues and contribute to the scientific community.” He added, “I always try to offer fair and constructive feedback, just as I hope to receive for my own research.” #PRW2026
October 9, 2026 at 5:28 PM
For Satoshi Minami, MD, PhD, a 2026 Top 5 #ASNKidney360 reviewer, peer review is “a valuable opportunity to support colleagues and contribute to the scientific community.” He added, “I always try to offer fair and constructive feedback, just as I hope to receive for my own research.” #PRW2026
A 2026 Top 5 #ASNCJASN reviewer, Dr. Ilia Beberashvili, shares: “The value of peer review lies not only in identifying limitations, but also in helping authors make their work clearer, stronger, and more clinically meaningful. It advances both science and patient care.” #PRW2026
October 7, 2026 at 5:59 PM
Discussing peer review, Manuel Praga, MD, noted “the work of a reviewer for high-quality scientific journals like JASN is crucial for maintaining high standards of rigor, quality, originality, and independence. These values are even more essential today.” Top 5 #ASNJASN reviewer 2026. #PRW2026
October 5, 2026 at 3:04 PM
A 2026 Top 5 #ASNKidney360 reviewer, Dr. Abinet Aklilu, shares: “Peer review is both a privilege and a responsibility. By providing constructive feedback, we can strengthen manuscripts and give back to a process that benefits us all as authors.” #PRW2026
@abinetaklilu.bsky.social
@abinetaklilu.bsky.social
October 2, 2026 at 7:12 PM
A 2026 Top 5 #ASNKidney360 reviewer, Dr. Abinet Aklilu, shares: “Peer review is both a privilege and a responsibility. By providing constructive feedback, we can strengthen manuscripts and give back to a process that benefits us all as authors.” #PRW2026
@abinetaklilu.bsky.social
@abinetaklilu.bsky.social
Thank you to Dr. Syed Ali Husain, a 2026 Top 5 #ASNJASN reviewer, who shared: “Peer review allows me to contribute to the scientific community & help improve the quality of research in nephrology. Participating in peer review also significantly increases the quality of my own research.” #PRW2026
September 28, 2026 at 3:03 PM
One of the Top 5 #ASNKidney360 reviewers of 2026, Dr. Sandesh Parajuli, shares: “Peer review is an essential part of scientific publishing and an important academic responsibility. I consider it a privilege to contribute to this process and give back to the academic community.” #PRW2026
September 25, 2026 at 4:08 PM
One of the Top 5 #ASNKidney360 reviewers of 2026, Dr. Sandesh Parajuli, shares: “Peer review is an essential part of scientific publishing and an important academic responsibility. I consider it a privilege to contribute to this process and give back to the academic community.” #PRW2026
A 2026 Top 5 #ASNCJASN reviewer, Dr. Gangkee Ko, notes: “To me, peer review is not simply about judging a manuscript. It is about learning from each other and contributing, in a small but meaningful way, to the progress of our field. It is both a responsibility and a privilege.” #PRW2026
September 24, 2026 at 3:08 PM
Closing out #PRW2026 with another interview!
Ching-ho Chang shares what makes a helpful review, a valuable piece of peer-review advice, and looking back at Barbara McClintock’s Nobel-winning work—initially met with skepticism—whether he encountered a paper that changed his mind over time?
1/5🧵
Ching-ho Chang shares what makes a helpful review, a valuable piece of peer-review advice, and looking back at Barbara McClintock’s Nobel-winning work—initially met with skepticism—whether he encountered a paper that changed his mind over time?
1/5🧵
September 18, 2026 at 6:02 PM
Closing out #PRW2026 with another interview!
Ching-ho Chang shares what makes a helpful review, a valuable piece of peer-review advice, and looking back at Barbara McClintock’s Nobel-winning work—initially met with skepticism—whether he encountered a paper that changed his mind over time?
1/5🧵
Ching-ho Chang shares what makes a helpful review, a valuable piece of peer-review advice, and looking back at Barbara McClintock’s Nobel-winning work—initially met with skepticism—whether he encountered a paper that changed his mind over time?
1/5🧵
To close out Peer Review Week, we asked John Schuetz, PhD, FASPET, and Editor-in-Chief of ASPET Discovery, for his thoughts on the advancement of AI in scientific publishing.
Learn more about ASPET Discovery: https://www.aspetdiscovery.org/
#peerreview #peerreviewweek #prw2026 #pharmsky 🧪
Learn more about ASPET Discovery: https://www.aspetdiscovery.org/
#peerreview #peerreviewweek #prw2026 #pharmsky 🧪
September 18, 2026 at 6:00 PM
To close out Peer Review Week, we asked John Schuetz, PhD, FASPET, and Editor-in-Chief of ASPET Discovery, for his thoughts on the advancement of AI in scientific publishing.
Learn more about ASPET Discovery: https://www.aspetdiscovery.org/
#peerreview #peerreviewweek #prw2026 #pharmsky 🧪
Learn more about ASPET Discovery: https://www.aspetdiscovery.org/
#peerreview #peerreviewweek #prw2026 #pharmsky 🧪
The Cancer Epidemiology, Biomarkers & Prevention Reviewer Training Program provides a unique opportunity to gain peer reviewer experience and to become more effective at scientific peer review. Learn more: buff.ly/VZdrxTw #PeerReviewWeek #PRW2026
September 18, 2026 at 9:43 PM
The Cancer Epidemiology, Biomarkers & Prevention Reviewer Training Program provides a unique opportunity to gain peer reviewer experience and to become more effective at scientific peer review. Learn more: buff.ly/VZdrxTw #PeerReviewWeek #PRW2026
Kristen Overstreet talks with Randy Townsend about recognizing reviewer fatigue, its connection to mental health, and why expanding and supporting the reviewer pool requires more than simply finding more people.
@peerreviewweek.bsky.social
#PeerReviewWeek #PRW2026
@peerreviewweek.bsky.social
#PeerReviewWeek #PRW2026
September 18, 2026 at 2:03 PM
Kristen Overstreet talks with Randy Townsend about recognizing reviewer fatigue, its connection to mental health, and why expanding and supporting the reviewer pool requires more than simply finding more people.
@peerreviewweek.bsky.social
#PeerReviewWeek #PRW2026
@peerreviewweek.bsky.social
#PeerReviewWeek #PRW2026
Strong peer review advances nephrology research and scientific rigor. This #PRW2026, Kidney360 recognizes its Top 5 reviewers of 2026: Drs. Sandesh Parajuli, Satoshi Minami, Keiichi Sumida, Luis Rafael Álvarez Velázquez, and Abinet Aklilu. #ASNKidney360
September 18, 2026 at 7:07 PM
Strong peer review advances nephrology research and scientific rigor. This #PRW2026, Kidney360 recognizes its Top 5 reviewers of 2026: Drs. Sandesh Parajuli, Satoshi Minami, Keiichi Sumida, Luis Rafael Álvarez Velázquez, and Abinet Aklilu. #ASNKidney360
We're concluding #PeerReviewWeek by sharing this guide to serve as a quick reference for reasons to consider recommending to reject, accept, or invite revisions to a manuscript: https://bit.ly/3V1JCnS. Thank you to our peer reviewers! #PRW2026 #PeerReview #ScholarlyPublishing
September 18, 2026 at 5:00 PM
We're concluding #PeerReviewWeek by sharing this guide to serve as a quick reference for reasons to consider recommending to reject, accept, or invite revisions to a manuscript: https://bit.ly/3V1JCnS. Thank you to our peer reviewers! #PRW2026 #PeerReview #ScholarlyPublishing
Fast & Fair is our initiative to provide authors with faster peer review decisions without compromising quality. The goal is to deliver decisions, with reviews, within 7 business days from submission. #PeerReviewWeek #PRW2026 journals.biologists.com/bio/pages/fa...
September 18, 2026 at 9:30 AM
Fast & Fair is our initiative to provide authors with faster peer review decisions without compromising quality. The goal is to deliver decisions, with reviews, within 7 business days from submission. #PeerReviewWeek #PRW2026 journals.biologists.com/bio/pages/fa...
AI can support peer review, but scientific judgement still has to come from people.
That was one of the clearest messages from our Peer Review Week roundtable with Frontiers in Immunology editors.
Hear more from our editors ➡️ fro.ntiers.in/PRW2026-Roun...
#PRW2026
That was one of the clearest messages from our Peer Review Week roundtable with Frontiers in Immunology editors.
Hear more from our editors ➡️ fro.ntiers.in/PRW2026-Roun...
#PRW2026
September 18, 2026 at 10:00 AM
AI can support peer review, but scientific judgement still has to come from people.
That was one of the clearest messages from our Peer Review Week roundtable with Frontiers in Immunology editors.
Hear more from our editors ➡️ fro.ntiers.in/PRW2026-Roun...
#PRW2026
That was one of the clearest messages from our Peer Review Week roundtable with Frontiers in Immunology editors.
Hear more from our editors ➡️ fro.ntiers.in/PRW2026-Roun...
#PRW2026